Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
1.380
-0.030 (-2.13%)
At close: Oct 31, 2024, 4:00 PM
1.390
+0.010 (0.72%)
After-hours: Oct 31, 2024, 6:39 PM EDT

Atossa Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Selling, General & Admin
13.1514.0412.6111.31810.62
Upgrade
Research & Development
17.4217.3315.089.216.616.65
Upgrade
Operating Expenses
30.5731.3827.6920.5214.6117.27
Upgrade
Operating Income
-30.57-31.38-27.69-20.52-14.61-17.27
Upgrade
Interest & Investment Income
4.724.340.880.01--
Upgrade
Other Non Operating Income (Expenses)
-0.06-0.07-0.15-0.09-3.220.03
Upgrade
EBT Excluding Unusual Items
-25.91-27.1-26.96-20.61-17.83-17.24
Upgrade
Gain (Loss) on Sale of Investments
--2.99----
Upgrade
Pretax Income
-25.91-30.09-26.96-20.61-17.83-17.24
Upgrade
Earnings From Continuing Operations
-25.91-30.09-26.96-20.61-17.83-17.24
Upgrade
Net Income
-25.91-30.09-26.96-20.61-17.83-17.24
Upgrade
Preferred Dividends & Other Adjustments
----4.5-
Upgrade
Net Income to Common
-25.91-30.09-26.96-20.61-22.33-17.24
Upgrade
Shares Outstanding (Basic)
126126127117118
Upgrade
Shares Outstanding (Diluted)
126126127117118
Upgrade
Shares Change (YoY)
-0.86%-0.43%8.27%934.13%33.09%104.36%
Upgrade
EPS (Basic)
-0.21-0.24-0.21-0.18-1.97-2.03
Upgrade
EPS (Diluted)
-0.21-0.24-0.21-0.18-1.97-2.03
Upgrade
Free Cash Flow
-18.69-20.96-20.79-16.48-11.58-9.14
Upgrade
Free Cash Flow Per Share
-0.15-0.17-0.16-0.14-1.02-1.08
Upgrade
EBITDA
-30.55-31.35-27.68-20.5-14.56-17.21
Upgrade
D&A For EBITDA
0.030.020.010.020.050.05
Upgrade
EBIT
-30.57-31.38-27.69-20.52-14.61-17.27
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.